Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015 Key
This presentation is the property of its rightful owner.
Sponsored Links
1 / 7

Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015 Key Trends, Size... PowerPoint PPT Presentation


  • 72 Views
  • Uploaded on
  • Presentation posted in: Industry

Researchmoz added Most up-to-date research on "Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015" to its huge collection of research reports.Global Markets Directs, Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015, provides an overview of the Metastatic Biliary Tract Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Biliary Tract Cancer and special features on late-stage and discontinued projects.To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=359945Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.Scope- The report provides a snapshot of the global therapeutic landscape of Metastatic Biliary Tract Cancer- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities- The report reviews key players involved in the therapeutics development for Metastatic Biliary Tract Cancer and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects- A review of the Metastatic Biliary Tract Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages- A detailed assessment of monotherapy and combination therapy pipeline projects- Coverage of the Metastatic Biliary Tract Cancer pipeline on the basis of target, MoA, route of administration and molecule type- Latest news and deals relating related to pipeline productsBrowse Detail Report With TOC @ http://www.researchmoz.us/metastatic-biliary-tract-cancer-pipeline-review-h2-2015-report.htmlReasons to buy- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Metastatic Biliary Tract Cancer- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Metastatic Biliary Tract Cancer pipeline depth and focus of Indication therapeutics- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipelineBrowse All Reports in Pharmaceutical Category @ http://www.researchmoz.us/pharmaceutical-market-reports-38.htmlTable of ContentsTable of Contents 2List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Metastatic Biliary Tract Cancer Overview 6Therapeutics Development 7Pipeline Products for Metastatic Biliary Tract Cancer - Overview 7Pipeline Products for Metastatic Biliary Tract Cancer - Comparative Analysis 8Metastatic Biliary Tract Cancer - Therapeutics under Development by Companies 9Metastatic Biliary Tract Cancer - Pipeline Products Glance 10Clinical Stage Products 10Metastatic Biliary Tract Cancer - Products under Development by Companies 11Metastatic Biliary Tract Cancer - Companies Involved in Therapeutics Development 12Array BioPharma Inc. 12AstraZeneca Plc 13GlaxoSmithKline Plc 14Novartis AG 15OncoTherapy Science, Inc. 16Metastatic Biliary Tract Cancer - Therapeutics Assessment 17Assessment by Monotherapy Products 17Assessment by Combination Products 18Assessment by Target 19Assessment by Mechanism of Action 21Assessment by Route of Administration 23Assessment by Molecule Type 24Drug Profiles 26binimetinib - Drug Profile 26Product Description 26Mechanism of Action 26R&D Progress 26dabrafenib mesylate trametinib dimethyl sulfoxide - Drug Profile 31Product Description 31Mechanism of Action 31R&D Progress 31OCVC-01 - Drug Profile 33Product Description 33Mechanism of Action 33R&D Progress 33For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-report.htmlAbout ResearchMozResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.For More Information Kindly Contact: ResearchMozMr. Nachiket Ghumare,Tel: 1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [email protected] @ http://www.researchmoz.us/

Download Presentation

Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015 K...

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015 Key

Trends, Size, Growth, Shares And Forecast Research Report

Researchmoz added Most up-to-date research on "Metastatic Biliary Tract

Cancer - Pipeline Review, H2 2015" to its huge collection of research

reports.

Global Markets Directs, Metastatic Biliary Tract Cancer - Pipeline Review, H2 2015,

provides an overview of the Metastatic Biliary Tract Cancers therapeutic pipeline.

This report provides comprehensive information on the therapeutic development

for Metastatic Biliary Tract Cancer, complete with comparative analysis at various

stages, therapeutics assessment by drug target, mechanism of action (MoA), route

of administration (RoA) and molecule type, along with latest updates, and featured

news and press releases. It also reviews key players involved in the therapeutic

development for Metastatic Biliary Tract Cancer and special features on late-stage

and discontinued projects.


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?

type=S&repid=359945

Global Markets Directs report features investigational drugs from across globe

covering over 20 therapy areas and nearly 3,000 indications. The report is built

using data and information sourced from Global Markets Directs proprietary

databases, Company/University websites, SEC filings, investor presentations and

featured press releases from company/university sites and industry-specific third

party sources, put together by Global Markets Directs team. Drug profiles/records

featured in the report undergoes periodic updation following a stringent set of

processes that ensures that all the profiles are updated with the latest set of

information. Additionally, processes including live news & deals tracking, browser

based alert-box and clinical trials registries tracking ensure that the most recent

developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective

counter strategies to gain competitive advantage. It strengthens R&D pipelines by

identifying new targets and MOAs to produce first-in-class and best-in-class

products.

Scope

- The report provides a snapshot of the global therapeutic landscape of Metastatic

Biliary Tract Cancer


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

- The report reviews key pipeline products under drug profile section which

includes, product description, MoA and R&D brief, licensing and collaboration

details & other developmental activities

- The report reviews key players involved in the therapeutics development for

Metastatic Biliary Tract Cancer and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Metastatic Biliary Tract Cancer products under development by

companies and universities/research institutes based on information derived from

company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from

pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Metastatic Biliary Tract Cancer pipeline on the basis of target,

MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Browse Detail Report With TOC @ http://www.researchmoz.us/metastatic-

biliary-tract-cancer-pipeline-review-h2-2015-report.html

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to

formulate effective R&D development strategies


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

- Identify emerging players with potentially strong product portfolio and create

effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading

companies

- Identify and understand important and diverse types of therapeutics under

development for Metastatic Biliary Tract Cancer

- Plan mergers and acquisitions effectively by identifying key players of the most

promising pipeline

- Devise corrective measures for pipeline projects by understanding Metastatic

Biliary Tract Cancer pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying

prospective partners with the most attractive projects to enhance and expand

business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and

understanding the factors that drove them from pipeline

Browse All Reports in Pharmaceutical Category @

http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

Introduction 5

Global Markets Direct Report Coverage 5

Metastatic Biliary Tract Cancer Overview 6

Therapeutics Development 7

Pipeline Products for Metastatic Biliary Tract Cancer - Overview 7

Pipeline Products for Metastatic Biliary Tract Cancer - Comparative Analysis 8

Metastatic Biliary Tract Cancer - Therapeutics under Development by Companies 9

Metastatic Biliary Tract Cancer - Pipeline Products Glance 10

Clinical Stage Products 10

Metastatic Biliary Tract Cancer - Products under Development by Companies 11

Metastatic Biliary Tract Cancer - Companies Involved in Therapeutics Development

12

Array BioPharma Inc. 12

AstraZeneca Plc 13

GlaxoSmithKline Plc 14

Novartis AG 15

OncoTherapy Science, Inc. 16

Metastatic Biliary Tract Cancer - Therapeutics Assessment 17

Assessment by Monotherapy Products 17

Assessment by Combination Products 18

Assessment by Target 19

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 24


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

Drug Profiles 26

binimetinib - Drug Profile 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

dabrafenib mesylate + trametinib dimethyl sulfoxide - Drug Profile 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

OCVC-01 - Drug Profile 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

For Market Research Latest Reports Visit @ http://www.researchmoz.us/latest-

report.html

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports &

Industry Analysis. We fulfill all your research needs spanning across industry verticals with

our huge collection of market research reports. We provide our services to all sizes of

organizations and across all industry verticals and markets. Our Research Coordinators

have in-depth knowledge of reports as well as publishers and will assist you in making an


Metastatic biliary tract cancer pipeline review h2 2015 key trends size growth shares and forecast research report

informed decision by giving you unbiased and deep insights on which reports will satisfy

your needs at the best price.

For More Information Kindly Contact:

ResearchMoz

Mr. Nachiket Ghumare,

Tel: +1-518-621-2074

USA-Canada Toll Free: 866-997-4948

Email: [email protected]

Website: http://www.researchmoz.us/


  • Login